Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LDHA | P00338 | 1/20 | 0.42 |
| ▸ | SRR | Q9GZT4 | 1/20 | 0.42 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.39 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.39 |
| ▸ | GRM1 | Q13255 | 2/20 | 0.39 |
| ▸ | GRM2 | Q14416 | 2/20 | 0.39 |
| ▸ | GRM8 | O00222 | 1/20 | 0.39 |
| ▸ | GRM6 | O15303 | 1/20 | 0.39 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.39 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.39 |
| ▸ | GSR | P00390 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | GRM5 | P41594 | 1/20 | 0.39 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.39 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.39 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.39 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.39 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.39 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.39 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28219859 | 0.97 | LDHA (0.40) | LDHASRRGRIK1GRIK2GRM1 | |
| Hydrochloric Acid SCHEMBL5422917 | 0.97 | LDHA (0.40) | LDHASRRGRIK1GRIK2GRM1 | |
| Hydrochloric Acid SCHEMBL5422913 | 0.97 | LDHA (0.40) | LDHASRRGRIK1GRIK2GRM1 | |
| Malonic Acid SCHEMBL9786773 | 0.82 | LDHA (0.56) | LDHASRRGRIK1GRIK2GRM1 | |
| SCHEMBL8585811 | 0.77 | — | — | |
| SCHEMBL1332607 | 0.76 | GRM8 (0.48) | GRIK1GRIK2GRM1GRM2GRM8 | |
| SCHEMBL133286 | 0.74 | — | — | |
| SCHEMBL133287 | 0.74 | — | — | |
| SCHEMBL27324011 | 0.74 | — | — | |
| SCHEMBL1468656 | 0.74 | LDHA (0.38) | LDHASRRGRIK1GRIK2GRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114373510-B | Metabolic marker for diagnosing or monitoring lung cancer and screening method and application thereof | 武汉迈特维尔医学科技有限公司 | 2023-12-01 | — | — | CN | disclosed |
| WO-2023083197-A1 | METABOLIC MARKER FOR DIAGNOSING OR MONITORING LUNG CANCER, AND SCREENING METHOD THEREFOR AND USE THEREOF | 武汉迈特维尔医学科技有限公司 | 2023-05-19 | — | — | WO | disclosed |
| CN-114373510-A | Metabolic marker for lung cancer diagnosis or monitoring and screening method and application thereof | 武汉迈特维尔生物科技有限公司 | 2022-04-19 | — | — | CN | disclosed |
| US-10905731-B2 | Methods and related compositions for reducing oxidative stress | GATEWAY HEALTH ALLIANCES, INC. | 2021-02-02 | — | — | US | disclosed |
| US-20200376058-A1 | METHODS AND RELATED COMPOSITIONS FOR REDUCING OXIDATIVE STRESS | GATEWAY HEALTH ALLIANCES, INC. | 2020-12-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10905731-B2 | Methods and related compositions for reducing oxidative stress | CAT, PRDX3, PRDX6 | LDHA 1375/4885SRR 2370/4885GRIK1 425/4885 |
| US-20200376058-A1 | METHODS AND RELATED COMPOSITIONS FOR REDUCING OXIDATIVE STRESS | CAT, PRDX3, PRDX6 | LDHA 1375/4885SRR 2370/4885GRIK1 425/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.